PETALING JAYA: Pathology & Clinical Laboratory (M) Sdn Bhd, a South-East Asian medical testing company, is considering selling its business in Malaysia which could fetch about US$200mil (RM949mil) in a transaction, according to people with knowledge of the matter.
Pathlab, as the company is known, is working with an adviser on the potential divestment, the people said.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
